Specialty Pharmacy Times: July/August

From the Chairman
Where Does Independent Specialty Pharmacy Fit in the Era of Consolidation?
Within this evolving new world of health care are the questions surrounding the future of smaller independent pharmacies.
Importance of Hospital Specialty Pharmacies Grows Amid Shifting Oncology Landscape
A specialty pharmacy’s specific expertise and experience in supporting patients with cancer is among its most essential attributes.
Clinical Insights
Ivosidenib for Relapsed/Refractory Acute Myeloid Leukemia
On July 20, 2018, the FDA approved ivosidenib (Tibsovo) as a treatment option for adult patients with relapsed/refractory acute myeloid leukemia, specifically with a mutation in the IDH1 gene.
Keycentrix: The “Key” to Innovative Specialty Pharmacy Technology
Keycentrix, a software and technology company specializing in pharmacy and health care, develops and implements technology solutions with pharmacists in mind.
Viewpoints: The Last Word
Cannabidiol Made Simple
Cannabidiol (CBD) has certainly drawn significant attention over the past few months.
Compliance Corner
Changes to USP Compounding Chapters Are on the Horizon
As the deadline for full implementation approaches, hospitals must create an action plan and timeline for completion.
Co-pay Accumulator Programs: Behind the Controversy
With ongoing growth across the board, plan sponsors are continuously searching for ways to minimize the impact on their bottom line.
The Changing Clinical Assessment: An Overview and Next-Level Challenges
The clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
Distributors Reveal the Road Map to Successful Specialty Therapy Launches
A strong partnership can support the successful commercialization of a product, position the therapy to meet a manufacturer’s business goals, and provide patients with an option to improve their health and quality of life.
Creative Financing for Innovative, Curative Therapies
States are getting inventive in their approaches to meeting the health care needs of their citizens, especially when it comes to curative treatments for conditions that have a high prevalence rate.
Independent Specialty Pharmacy: Staying Relevant in the Face of Unprecedented Challenges
Independent specialty pharmacy must see health care cost through a different lens.
Overcoming Challenges in Health-System Specialty Pharmacy
It is important to promote the ongoing development of best practices for integrated specialty pharmacies in academic health systems.
Disease State Management
Experts Discuss Best Treatment Practices and Emerging Therapies for Axial Spondyloarthritis
In a Specialty Pharmacy Times® Insights video series, experts Atul A. Deodhar, MD, and Hillary Norton, MD, discussed clinical best practices surrounding the diagnosis, management, and treatment of AxSpA, including an overview of available therapies.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.